Efficacy and Cost-effectiveness of Orthodontic Retention Protocols (orthoretenti)

May 3, 2022 updated by: silvija kanižaj ugrin, Poliklinika Orthonova
Objective is to assess changes of dentition and periodontium, and hygiene in retention after the end of the active phase of orthodontic treatment, and relationship with gender, type of retention appliance, pre-therapeutic condition of dentition and duration of active phase of treatment.

Study Overview

Status

Recruiting

Conditions

Detailed Description

A total of 152 subjects will be recruited and randomly assigned into three groups. First group will have a square 8-stranded 0.673x0.268 mm retainer wire bonded in mandibular teeth after completing the active phase of comprehensive orthodontic treatment with fixed appliances. Retainer will be bonded on lingual site canine to canine on each tooth. Second group will have a round 6-stranded 0.40 mm retainer in mandible. Third group will be without fixed retainer, only with thermoplastic vacuum-formed removable Essix retainer in mandible.

Subjects will be examined before orthodontic treatment (T0), upon completion of treatment (T1), six months in retention (T2), two years (T3) and three years in retention (T4). Changes in intercanine width, relapse (unexpected tooth movements), retainer failure, accumulation of biofilm, calculus and gingivitis will be assessed.

Study Type

Interventional

Enrollment (Anticipated)

152

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Zagreb, Croatia, 10000
        • Recruiting
        • Poliklinika Orthonova
        • Contact:

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

11 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria: finished orthodontic treatment, participants must have all permanent teeth Exclusion Criteria: hypodontia, missing teeth

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: fixed mandibular lingual rectangular retainer 0.673 x 0.268 mm
0.673 x 0.268 mm 8-stranded wire Bond A Braid (Reliance Orthodontic Products, USA) will be bonded in mandible canine to canine on each tooth using Filtek flowable composite (Ivoclar Vivadent, Lichtenstein) and Multilink adhesive (3M, USA).
bonded lingual mandibular fixed retainer on frontal teeth 33-43
Experimental: fixed mandibular lingual round retainer 0.40 mm
0.40 mm round 6-stranded wire (Forestadent, Germany) will be bonded on 6 mandibular frontal teeth, canine to canine on each tooth using Filtek flowable composite (Ivoclar Vivadent, Lichtenstein) and Multilink adhesive (3M, USA).
bonded lingual mandibular fixed retainer on frontal teeth 33-43
Active Comparator: removable mandibular retainer
Group without fixed retainer will be wearing removable thermoplastic vacuum-formed Essix retainer
thermoplastic vacuum-formed removable mandibular retainer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
severity of relapse (unexpected tooth movement in mandibular frontal area) at 1 year
Time Frame: 1 year
the unabbreviated scale title: Little Irregularity Index (used to measure the crowding)- numerical rating scale in millimeters the minimum and maximum values: 0,10 higher scores mean a worse outcome lower scores mean a better outcome
1 year
severity of relapse (unexpected tooth movement in mandibular frontal area) at 2 years
Time Frame: 2 years
the unabbreviated scale title: Little Irregularity Index (used to measure the crowding)- numerical rating scale in millimeters the minimum and maximum values: 0,10 higher scores mean a worse outcome lower scores mean a better outcome
2 years
severity of relapse (unexpected tooth movement in mandibular frontal area) at 3 years
Time Frame: 3 years
the unabbreviated scale title: Little Irregularity Index (used to measure the crowding)- numerical rating scale in millimeters the minimum and maximum values: 0,10 higher scores mean a worse outcome lower scores mean a better outcome
3 years
incidence of retainer failure (debonding, breakage) at 2 years
Time Frame: 2 years
percentage of cases with at least one fixed retainer failure, the minimum and maximum values 0%,100% higher scores mean a worse outcome, lower scores mean a better result
2 years
incidence of retainer failure (debonding, breakage) at 3 years
Time Frame: 3 years
percentage of cases with at least one fixed retainer failure, the minimum and maximum values 0%,100% higher scores mean a worse outcome, lower scores mean a better result
3 years
extent of biofilm accumulation at 2 years
Time Frame: 2 years
the unabbreviated scale title: Silness and Loe Plaque Index-ratio of measuring sites in mandibular central sextant; the minimum and maximum values 0%,100%, higher scores mean a worse outcome, lower scores mean a better result
2 years
extent of biofilm accumulation at 3 years
Time Frame: 3 years
the unabbreviated scale title: Silness and Loe Plaque Index-ratio of measuring sites in mandibular central sextant; the minimum and maximum values 0%,100%, higher scores mean a worse outcome, lower scores mean a better result
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of intercanine width change
Time Frame: 3 years
percentage of cases with intercanine width change, the minimum and maximum values 0%,100% higher scores mean a worse outcome, lower scores mean a better result
3 years
changes of intercanine width
Time Frame: 2 years, 3 years
the unabbreviated scale title: intercanine width change in millimeters, the minimum and maximum values 0,5, higher scores mean a worse outcome, lower result mean a better outcome
2 years, 3 years
extent of calculus accumulation at 2 years
Time Frame: 2 years
the unabbreviated scale title: Calculus Surface Index (CSI)-ratio of measuring sites in mandibular central sextant; the minimum and maximum values 0%,100%, higher scores mean a worse outcome, lower scores mean a better outcome
2 years
extent of calculus accumulation at 3 years
Time Frame: 3 years
the unabbreviated scale title: Calculus Surface Index (CSI)-ratio of measuring sites in mandibular central sextant; the minimum and maximum values 0%,100%, higher scores mean a worse outcome, lower scores mean a better outcome
3 years

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
incidence of relapse at 2 years
Time Frame: 2 years
the unabbreviated scale title: percentage of relapsed cases; the minimum and maximum values 0%,100%, higher scores mean a worse outcome, lower scores mean a better outcome
2 years
incidence of relapse at 3 years
Time Frame: 3 years
the unabbreviated scale title: percentage of relapsed cases; the minimum and maximum values 0%,100%, higher scores mean a worse outcome, lower scores mean a better outcome
3 years
extent of gingivitis at 2 years
Time Frame: 2 years
the unabbreviated scale title: Bleeding on probing (BOP)-ratio of measuring sites in mandibular central sextant; the minimum and maximum values 0%,100%, higher scores mean a worse outcome, lower scores mean a better result
2 years
extent of gingivitis at 3 years
Time Frame: 3 years
the unabbreviated scale title: Bleeding on probing (BOP)-ratio of measuring sites in mandibular central sextant; the minimum and maximum values 0%,100%, higher scores mean a worse outcome, lower scores mean a better result
3 years
duration of orthodontic treatment in months
Time Frame: 1 year
the unabbreviated scale title: numerical rating scale the minimum and maximum values: 0,30
1 year
satisfaction with stability of results in retention period
Time Frame: 3 years
Participant's satisfaction with stability of results as assessed using a 5-point Likert scale. Scores range from "very unsatisfied" (1) to "very satisfied" (5). Higher scores mean a better outcome, lower scores mean a worse outcome
3 years
costs total
Time Frame: 3 years
calculation of costs of retention: failures and new retainers in euros
3 years
loss of productivity
Time Frame: 3 years
the unabbreviated scale title: number of check-ups in retention period; the minimum and maximum values 0,10; higher scores mean a worse outcome, lower scores mean a better result the minimum and maximum values: 0,30
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Silvija Kanižaj Ugrin, DDM, Poliklinika Orthonova

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 15, 2020

Primary Completion (Anticipated)

November 15, 2022

Study Completion (Anticipated)

November 15, 2023

Study Registration Dates

First Submitted

October 2, 2021

First Submitted That Met QC Criteria

November 3, 2021

First Posted (Actual)

November 16, 2021

Study Record Updates

Last Update Posted (Actual)

May 9, 2022

Last Update Submitted That Met QC Criteria

May 3, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 66771011

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

IPD Plan Description

on request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe